chloramphenicol has been researched along with ethambutol in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (56.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (24.00) | 29.6817 |
| 2010's | 4 (16.00) | 24.3611 |
| 2020's | 1 (4.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dobson, RA; Johnson, RE; O'Connor, JR; Soria, AE | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Gaillard, JL; Jackson, M; McDonnell, G; Niederweis, M; Skovierová, H; Svetlíková, Z | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bera, S; Mondal, D | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Jaeger, W | 1 |
| Sobue, I | 1 |
| Kimbel, KH | 1 |
| Satoyoshi, E; Wakata, N | 1 |
| Mayer, U | 1 |
| Tateishi, J | 1 |
| Sobue, I; Takayanagi, T | 1 |
| Cvibah, T; Feinstein, A; Schewach Millet, M; Ziprkowski, L | 1 |
| Jackson, EA; McLeod, DC | 1 |
| Hodges, GR; Snavely, SR | 1 |
| Bach, VT; Thadepalli, H | 1 |
| Lessell, S | 1 |
| Desbordes, JM; Hamard, H | 1 |
5 review(s) available for chloramphenicol and ethambutol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Insights of synthetic analogues of anti-leprosy agents.
Topics: Humans; Leprostatic Agents; Leprosy; Structure-Activity Relationship | 2019 |
[Exogenous toxic neuropathy (author's transl)].
Topics: Acrylamides; Adolescent; Adult; Aged; Aldrin; Carbon Disulfide; Chloramphenicol; Clioquinol; DDT; Disulfiram; Endrin; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Nervous System Diseases; Phenytoin; Sulfonamides; Thalidomide; Thiamphenicol; Trichloroethylene; Vincristine | 1976 |
The neurotoxicity of antibacterial agents.
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Central Nervous System Diseases; Cephalosporins; Chloramphenicol; Clindamycin; Colistin; Cranial Nerve Diseases; Dapsone; Erythromycin; Ethambutol; Humans; Lincomycin; Metronidazole; Nervous System Diseases; Neuromuscular Junction; Penicillins; Peripheral Nervous System Diseases; Polymyxin B; Sulfonamides; Tetracyclines; Vancomycin | 1984 |
[Iatrogenic pathology of the optic nerve].
Topics: Adrenal Cortex Hormones; Antiprotozoal Agents; Chloramphenicol; Contraceptives, Oral; Ethambutol; Female; Humans; Iatrogenic Disease; Isoniazid; Monoamine Oxidase Inhibitors; Optic Nerve Diseases; Phenytoin; Quinine; Radiotherapy; Surgical Procedures, Operative; Vitamins | 1982 |
20 other study(ies) available for chloramphenicol and ethambutol
| Article | Year |
|---|---|
Synthesis and antibacterial activity of 1-(arylamino)-1H-pyrroles and 4-(1H-pyrrol-1-ylimino)-2,5-cyclohexadienes.
Topics: Animals; Anti-Infective Agents; Antitubercular Agents; Biotransformation; Chemical Phenomena; Chemistry; Cyclohexanes; Female; Mice; Pyrroles; Rats; Rats, Inbred Strains | 1981 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Role of porins in the susceptibility of Mycobacterium smegmatis and Mycobacterium chelonae to aldehyde-based disinfectants and drugs.
Topics: Antitubercular Agents; Disinfectants; Drug Resistance, Bacterial; Glutaral; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Mycobacterium chelonae; Mycobacterium smegmatis; o-Phthalaldehyde; Porins | 2009 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
[Acquired colour-vision-deficiencies caused by side-effects of pharmacotherapy (author's transl)].
Topics: Antipsychotic Agents; Chloramphenicol; Chloroquine; Chlorpropamide; Color Vision Defects; Contraceptives, Oral; Digitoxin; Ethambutol; Humans; Indomethacin; Monoamine Oxidase Inhibitors; Optic Neuritis; Phenothiazines; Retinal Diseases; Sparsomycin | 1977 |
[Toxicological evaluation criteria (secondary action aspects)].
Topics: Anti-Infective Agents; Cephalosporins; Chloramphenicol; Erythromycin; Ethambutol; Gentamicins; Humans; Isoniazid; Lincomycin; Nalidixic Acid; Neomycin; Nitrofurantoin; Penicillins; Rifampin; Streptomycin; Sulfonamides; Tetracyclines | 1977 |
[Experimental studies on neurotoxicity of ethambutol and chloramphenicol - pathological and macroautoradiographic studies].
Topics: Animals; Chloramphenicol; Ethambutol; Female; Male; Nervous System Diseases; Rats | 1975 |
[The adverse effects of drugs on the eye].
Topics: Adrenal Cortex Hormones; Adult; Child; Child, Preschool; Chloramphenicol; Digitalis Glycosides; Drug-Related Side Effects and Adverse Reactions; Ethambutol; Eye Diseases; Female; Humans; Infant; Male; Quinolines | 1976 |
Comparative study of neurotoxicity of clioquinol, ethambutol, isoniazid and chloramphenicol in dogs.
Topics: Abdomen; Administration, Oral; Animals; Axons; Chloramphenicol; Clioquinol; Dogs; Ethambutol; Isoniazid; Myelin Sheath; Myelitis; Nervous System; Nervous System Diseases; Optic Nerve; Optic Neuritis; Pain; Quinolines; Spinal Cord | 1974 |
[Peripheral neuropathy caused by drug in toxication--direct invasion by drugs and ultrastructural changes of the tissue].
Topics: Animals; Chloramphenicol; Ethambutol; Iodine; Isoniazid; Mice; Microscopy, Electron; Peripheral Nervous System Diseases; Quinolines; Vincristine | 1974 |
Mycetoma pedis, a report of two cases.
Topics: Chloramphenicol; Dapsone; Ethambutol; Foot Dermatoses; Humans; Male; Middle Aged; Mycetoma; Radiography; Recurrence; Streptomyces; Streptomycin; Tetracycline | 1973 |
Pharmacokinetics and dosing of antimicrobial agents in renal impairment, Part II.
Topics: Anti-Infective Agents; Bacitracin; Chloramphenicol; Chloroquine; Clindamycin; Dapsone; Ethambutol; Humans; Isoniazid; Kidney Diseases; Methenamine; Nalidixic Acid; Neomycin; Nitrofurantoin; Sulfadimethoxine; Sulfamethizole; Sulfamethoxazole; Sulfamethoxypyridazine; Sulfisomidine; Sulfisoxazole; Vancomycin | 1974 |
Susceptibility of anaerobic bacteria in vitro to 23 antimicrobial agents.
Topics: Anaerobiosis; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacteroides fragilis; beta-Lactamases; Cephalosporins; Chloramphenicol; Clindamycin; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Penicillins; Rifampin; Spectinomycin; Tetracyclines | 1980 |
Toxic metabolic disorders of myelin --ophthalmological features.
Topics: Adolescent; Adult; Aged; Amblyopia; Child; Child, Preschool; Chloramphenicol; Contraceptives, Oral, Hormonal; Cyanides; Demyelinating Diseases; Disulfiram; Drug-Related Side Effects and Adverse Reactions; Ethambutol; Ethanol; Female; Humans; Hydroxyquinolines; Infant; Infant, Newborn; Male; Methanol; Middle Aged; Nicotiana; Optic Neuritis; Plants, Toxic | 1983 |